{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:37:09Z","timestamp":1776433029897,"version":"3.51.2"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.metop.2021.100083","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T18:43:26Z","timestamp":1611859406000},"page":"100083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Phenotype, genotype, and outcome of 25 Palestinian patients with hereditary tyrosinemia type 1"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-9957","authenticated-orcid":false,"given":"Imad","family":"Dweikat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Qawasmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysha","family":"Najeeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metop.2021.100083_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/ped.12503","article-title":"Hereditary tyrosinemia type 1 in Turkey: twenty year single-center experience","volume":"57","author":"Zeybek","year":"2015","journal-title":"Pediatr Int"},{"key":"10.1016\/j.metop.2021.100083_bib2","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1442-200X.2011.03427.x","article-title":"Tyrosinemia type 1 in Spain: mutational analysis, treatment and long-term outcome","volume":"53","author":"Couce","year":"2011","journal-title":"Pediatr Int"},{"key":"10.1016\/j.metop.2021.100083_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2017.101","article-title":"Diagnosis and treatment of tyrosinemia type 1: a US and Canadian consensus group review and recommendations","author":"Chinsky","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.metop.2021.100083_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10545-006-0203-5","article-title":"Cardiomyopathy in tyrosinemia type I is common but usually benign","volume":"29","author":"Arora","year":"2006","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.metop.2021.100083_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/humu.23047","article-title":"Silent tyrosinemia type I without elevated tyrosine or succinylacetone associated with liver cirrhosis and hepatocellular carcinoma","author":"Blackburn","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.metop.2021.100083_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-008-0793-1","article-title":"NTBC treatment in tyrosinemia type I: long-term outcome in French patients","volume":"31","author":"Masurel-Paulet","year":"2008","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.metop.2021.100083_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2014.07.021","article-title":"Early effect of NTBC on renal tubular dysfunction in hereditary tyrosinemia type I","volume":"113","author":"Maiorana","year":"2014","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.metop.2021.100083_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10545-008-0817-x","article-title":"Renal tubular function in children with tyrosinemia type I treated with nitisinone","volume":"31","author":"Santra","year":"2008","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.metop.2021.100083_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10545-011-9394-5","article-title":"Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC","volume":"35","author":"Thimm","year":"2012","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.metop.2021.100083_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymgmr.2017.01.016","article-title":"Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet","volume":"11","author":"Garcia","year":"2017","journal-title":"Molecular Genetics and Metabolism Reports"},{"key":"10.1016\/j.metop.2021.100083_bib11","first-page":"332","article-title":"Neurologic crisis IN hereditary tyrosinemia","author":"Mitchell","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.metop.2021.100083_bib12","article-title":"Mutation analysis of the FAH gene in Israeli patients with tyrosinemia type I","author":"Elpeleg","year":"2001","journal-title":"Human Mutation Mutation in Brief"},{"key":"10.1016\/j.metop.2021.100083_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejrad.2019.04.016","article-title":"Imaging liver nodules in tyrosinemia type-1: a retrospective review of 16 cases in pediatric tertiary hospital","volume":"116","author":"Ozcan","year":"2019","journal-title":"Eur J Radiol"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936821000074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936821000074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:55:01Z","timestamp":1762905301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936821000074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":13,"alternative-id":["S2589936821000074"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2021.100083","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotype, genotype, and outcome of 25 Palestinian patients with hereditary tyrosinemia type 1","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2021.100083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100083"}}